Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Receivables (2021)

Historic Receivables for Vistagen Therapeutics (VTGN) over the last 3 years, with Q1 2021 value amounting to $81200.0.

  • Vistagen Therapeutics' Receivables changed N/A to $81200.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $81200.0, marking a year-over-year change of. This contributed to the annual value of $81200.0 for FY2021, which is N/A changed from last year.
  • Per Vistagen Therapeutics' latest filing, its Receivables stood at $81200.0 for Q1 2021.
  • In the past 5 years, Vistagen Therapeutics' Receivables ranged from a high of $81200.0 in Q1 2021 and a low of $81200.0 during Q1 2021